Breaking News

Boehringer Inaugurates Biopharma Mfg. Facility in China

First phase investment of more than €70 million

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Boehringer Ingelheim recently inaugurated its commercial production site for biopharmaceuticals in Zhang Jiang Hi-tech Park of Shanghai, China. The site, with the first-phase investment of more than €70 million, is the first and only biopharmaceutical facility established by a leading multinational active biopharmaceutical manufacturer in China utilizing mammalian cell culture technology. With its global network of biopharmaceutical production sites in Biberach, Germany; Vienna, Austria; Fremont...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters